Literature DB >> 12570793

Angiotensin-converting enzyme inhibitors: mechanisms of action and implications in anesthesia practice.

Rahim Behnia1, Agostino Molteni, Rajko Igić.   

Abstract

This review summarizes physiology of circulating and local renin-angiotensin system (RAS), enzymatic properties and mechanism of action of angiotensin I converting enzyme inhibitors (ACEIs) on RAS, and implications of ACEIs in anesthetic management of patients treated with these drugs. ACEIs, through their effect on RAS, may improve cardiovascular functions, pulmonary dynamics, and body fluid homeostasis. Thus, ACEIs have become an integral part of management of patients with hypertension, congestive heart failure (CHF) and chronic renal disease. ACEIs, due to differences in their chemical structure, exert different pharmacological actions and can have protective or occasional damaging effects on different organs. The anesthesiologists are commonly involved in the management of patients treated with ACEIs. Thus, the role of ACEIs and their possible interaction with anesthetic agents must be an integral part of clinical decision-making during anesthesia Hemodynamic variation during anesthesia is mainly related to specific effects of anesthetic agents on sympathetic nervous system. Those with preoperative fasting, volume depletion and extended sympathetic blockade can have reduced vascular capacitance resulting in decreased venous return, reduced cardiac output and severe arterial hypotension. Angiotensin II (ANG2) a potent vasoconstrictor may counterbalance such hypotensive effect. During ACE inhibition ANG2 cannot counterbalance this hypotension. Thus, induction of anesthesia may cause severe hypotension in hypovolemic patients specifically in those receiving diuretics as a complement to ACEIs. Recent advances in RAS and the pharmacology of ACEIs have identified some predisposing factors and risks associated with anesthesia in patients treated with ACEIs. Practitioners should be vigilant, and readily have vasopressors, necessary fluids and other resuscitative measures for treatment of unexpected hemodynamic instability during anesthesia and surgery.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12570793     DOI: 10.2174/1381612033455413

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  9 in total

Review 1.  [Preoperative long-term therapy].

Authors:  K Buhre; L de Rossi; W Buhre
Journal:  Anaesthesist       Date:  2005-09       Impact factor: 1.041

2.  Preoperative risk factors of hemodynamic instability during laparoscopic adrenalectomy for pheochromocytoma.

Authors:  Sébastien Gaujoux; Stéphane Bonnet; Claude Lentschener; Jean-Marc Thillois; Denis Duboc; Jérôme Bertherat; Charles Marc Samama; Bertrand Dousset
Journal:  Surg Endosc       Date:  2015-12-18       Impact factor: 4.584

3.  [Preoperative administration of angiotensin-converting enzyme inhibitors].

Authors:  U Schirmer; W Schürmann
Journal:  Anaesthesist       Date:  2007-06       Impact factor: 1.041

4.  Chronic Renin-Angiotensin System (RAS) Blockade May Not Induce Hypotension During Anaesthesia for Bariatric Surgery.

Authors:  Guido Salvetti; Claudio Di Salvo; Giovanni Ceccarini; Antonio Abramo; Paola Fierabracci; Silvia Magno; Paolo Piaggi; Paolo Vitti; Ferruccio Santini
Journal:  Obes Surg       Date:  2016-06       Impact factor: 4.129

5.  Effects of hypertension on abdominal wall healing: experimental study in rats.

Authors:  Jair Morais Tostes; André Luís Watanabe; Luís Massaro Watanabe
Journal:  Surg Today       Date:  2007-03-09       Impact factor: 2.549

6.  Association between insertion/deletion polymorphism in angiotensin-converting enzyme gene and acute lung injury/acute respiratory distress syndrome: a meta-analysis.

Authors:  Akihisa Matsuda; Taro Kishi; Asha Jacob; Monowar Aziz; Ping Wang
Journal:  BMC Med Genet       Date:  2012-08-31       Impact factor: 2.103

7.  A Convenient RP-HPLC Method for Assay Bioactivities of Angiotensin I-Converting Enzyme Inhibitory Peptides.

Authors:  Wei Wang; Nan Wang; Yu Zhang; Zheng Cai; Qihe Chen; Guoqing He
Journal:  ISRN Biotechnol       Date:  2012-10-21

8.  Multifactorial Model and Treatment Approaches of Refractory Hypotension in a Patient Who Took an ACE Inhibitor the Day of Surgery.

Authors:  Karan Srivastava; Vikas Y Sacher; Craig T Nelson; John I Lew
Journal:  Case Rep Anesthesiol       Date:  2013-04-10

9.  Frequency of Intraoperative Hypotension After the Induction of Anesthesia in Hypertensive Patients with Preoperative Angiotensin-converting Enzyme Inhibitors.

Authors:  Fahad Salim; Fazal Khan; Muhammad Nasir; Rashid Ali; Ayesha Iqbal; Amir Raza
Journal:  Cureus       Date:  2020-01-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.